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Abstract: Nitric oxide synthase (NOS) that uses NADPH as a cofactor is an enzyme which produces
nitric oxide (NO) from L-arginine. Endothelial-derived (eNOS), inducible (iNOS) and neuronal (nNOS)
nitric oxide synthase are 3 known isoforms. Endothelial NO regulates the vascular tonus and causes
the dilatation of vessels, while NOS localized in the sarcolemma of striated muscle plays a role in the
regulation of muscle hemodynamics. Many authors have found differences in NO production in some
pathological conditions such as diabetes mellitus (DM), hypertension and atherosclerosis. In this
study, NADPH-diaphorase (NADPH-d) was histochemically employed to explore any changes in NO
production associated with the degree of DM, by detecting the enzyme in the muscle tissue. Diabetes
was induced by injecting Swiss albino rats with 65mg/kg of streptozotosin (STZ). Two, 4, 6 and 12
weeks after the STZ injection, the spinotrapezius muscles of the animals were fixed in
paraformaldehyde and NADPH-d histochemistry was applied to cryostat sections. Six and 12 weeks
after DM, NOS increased both in the muscles and the endothelial cells of arterioles, being more
prominent in the 12-week group in which the NADPH-d reaction was also localized in sarcoplasm
together with the sarcolemma of muscle fibers than in controls. NOS was more abundant in the 2ndand 3rd-order arterioles in diabetic animals than in controls. After the superfusion of the NW-nitroL-Arginine Methyl Ester (L-NMA) that inhibits NOS, the NADPH-d reaction was still present in 12week DM, while not in controls. ACh superfusion caused endothelial dilation and increased NO
production in both the control and diabetic groups. This increase was observed to be more
pronounced in diabetics than in controls. We also superfused sodium nitroprusside as a NO donor,
and found resulting dilation in arterioles, with differences between the control and DM groups, the
latter being more conspicuous.
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S›çanlarda Streptozotosin ile Oluflturulan Diabetes Mellitusda ‹skelet
Kas› ve Arteriollerde Nitrik Oksid Sentaz
Özet: Nitrik oksid sentaz (NOS), NADPH kofaktörünü kullanarak, L-argininden nitrik oksid (NO)
üretilmesini sa¤layan enzimdir. Endotel kaynakl› (eNOS), uyar›labilir (iNOS) ve nöronal (nNOS) olmak
üzere üç ayr› izoformu mevcuttur. Endotel kaynakl› NO, damar tonusunu düzenler ve damarlar›n
gevflemesine neden olur. Çizgili kas›n sarkolemmas›nda izlenen NOS da kas hemodinami¤inin
düzenlenmesinde rol oynar. Diabetes mellitus (DM) gibi baz› patolojik durumlarda NO üretiminde
farkl›l›klar ortaya ç›kmaktad›r. Bu çal›flmada, DM un derecesine ba¤l› olarak NO üretiminin de¤iflip
de¤iflmedi¤ini anlamak için NOS kofaktörü olan NADPH-d histokimyasal olarak uyguland› ve enzimin
doku düzeyindeki da¤›l›m› gösterildi. Bunun için Swiss albino s›çanlara 65 mg/kg streptozotosin (STZ)
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enjekte edilerek DM oluflturuldu. Enjeksiyondan 2, 4, 6 ve 12 hafta sonra hayvanlar›n spinotrapezius
kaslar› paraformaldehid ile tesbit edilerek, al›nan kriyostat kesitlerine NADPH-d yöntemi uyguland›.
DM un alt›nc› ve 12nci haftas›ndan sonra hem kaslarda hem de arteriollerin endotel hücrelerinde NOS
in artt›¤› gözlendi. DM lu kas fibrillerinde sarkolemma yan›nda sarkoplazmada da NADPH-d
reaksiyonu mevcuttu. Arteriollerin ikinci ve üçüncü dallanmalar›nda NOS miktar› kontrollardan fazla
idi. NOS inhibitörü olan L-NMA süperfüzyonundan sonra kontrollarda NOS görülmezken, diabetin
onikinci haftas›nda NADPH-d reaksiyonu gözlenmekteydi. ACh süperfüzyonu endotel kaynakl›
gevflemeye neden oldu ve NO üretimi hem kontrol grubunda hem de diabetik grupda artt›. Fakat bu
durum diabetik grupda çok daha belirgindi. Bir NO vericisi olan sodyum nitropurisid uyguland›¤›nda
arteriollerde gevfleme gözlendi ve NOS reaksiyonu bak›m›ndan kontroller ile dibetik grup aras›nda
fark vard›. Diabetik grupta bu reaksiyon da oldukça belirgindi.
Anahtar Sözcükler: Nitrik oksid sentaz (NOS), diabetes mellitus, iskelet kas›, arteriol

Introduction
Nitric oxide synthases are enzymes which produce nitric oxide (NO) from L-Arginine. Three
major isoforms of this enzyme have been isolated and characterized: endothelial (eNOS),
inducible (iNOS) and neuronal (nNOS). nNOS occurs in several cell types, including neurons and
skeletal muscle cells (1). In all vertebrate species, nNOS is present in the sarcolemma of muscle fibers (2, 3, 4). Recent reports indicate that skeletal muscle tonically produces NO and that
NO functions as an endogenous modulator of muscle physiology, at both the tissue and the cellular levels. NO derivatives appear to mediate cell-cell interactions, e.g., by modulating vascular
control. NO also acts directly on skeletal muscle fibers to influence both muscle metabolism and
contractile function (5). Endothelial NOS is widely expressed in endothelial cells throughout the
vascular bed. It is generally accepted that endothelium-derived NO is an important factor in the
control of basal vascular tone (6). In response to agents such as bradykinin and acetylcholine
or to mechanical forces such as shear stress, endothelia cells produce NO, which diffuses into
vascular smooth muscle cells and causes vasorelaxation. Arginine analogs such as NGmonomethyl-L-arginine (L-MMA) and L-nitroarginine are competetive inhibitors of NOS
enzymes (7).
Abnormalities in endothelial production of NO occur in atherosclerosis, diabetes and hypertension (8). In patients with insulin-dependent diabetes mellitus (IDDM), increased forearm and
skin blood flow are found, indicating vasodilation (9,10,11). It is not known whether microvascular changes in IDDM are linked to changes in endothelium-dependent vasoactive mechanisms.
When the production of NO rises, peripheral resistance falls and organ blood flow increases. An
increase in NO production has been suggested to occur in IDDM and to explain the vasodilation
that is typically observed (12,13). Other investigators, however, found the production or efficiency of NO to be diminished in experimental and human IDDM (14,15,16). The role of NO
with respect to changes in vasoreactivity in IDDM is controversial.
The aim of this study was to determine the NOS differences in skeletal muscle and the arterioles of muscle during DM.
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Materials and Methods
Experimental animals: Diabetes was induced in 36 male Swiss albino rats (250 g) by a single intraperitonial injection of 65 mg/kg Streptozotocin (STZ) dissolved in serum physiologic
solution. The animals were housed in individual cages and received commercial rat pellet chow
and water ad libitum. The rats were separated into 5 groups: I: 2-week DM (n=6), II: 4-week
DM (n=6), III: 6-week DM (n=6), IV: 12-week (n=6) DM and V: 12-week DM, which were also
separated into 3 groups superfused with 10-4 M Acetylcholine (ACh, n=4), 10-4 M sodium nitro-4
W
prusside (NP, n=4) or 10 M N -Nitro-L-Arginine Methyl ester (L-NMA, n=4) Time-matched
untreated rats were used as controls (n=10) for the first 4 groups. Controls of group V were
also separated into 3 subgroups which were superfused with ACh, NP or L-NMA. Glucose levels were determined weekly in all animals by glucometer (Bayer) in blood samples taken from
tail tip.
At the end of the diabetic periods, anesthesia was induced by injection of sodium penthothal
(70 mg/kg) intraperitoneally. Body temperature was kept at 37-38ºC by a heating table under
the rats during the experiment.
The spinotrapezius muscle was approached through a skin incision along the spine, after
which subcutaneous fat and fascia were carefully removed. The lateral border of the muscle was
freed and lifted with 4-5 atraumatic sutures to separate it from the underlying muscle layers,
as described by Gray (17) and Marshall (18). Tissues were superfused with saline solution during muscle preparation and drug application. The temperature of this solution was maintained
at 36ºC in groups I, II, III and IV and their controls, and the muscle was removed next to the
spine and fixed with 4% paraformaldehyde. In the other groups (subgroups of V) and their controls, the muscle was superfused with NO-dependent ACh for 3 minutes (n=4); NO donor NP
for 6 minutes (n=4); and NOS inhibitor L-NMA for 15 minutes (n=4). All drugs were prepared
with saline solution and after superfusions, muscles were removed and fixed.
NADPH-d histochemistry: Skeletal muscle was fixed in 4% paraformaldehyde in 0.1M phosphate buffer pH 7.4 for 2 hours, and tissue was cryoprotected in 20% sucrose in 0.1M phosphate buffer (pH 7.4) at 4ºC overnight. Ten-micrometer sections were cut with cryostat and
mounted on slides. These sections were incubated with 1mMβ-NADPH (Sigma), 0.5 mM
Nitroblue tetrazolium (Sigma) and 0.2% triton X-100 in 50 mM Tris-HCL pH 8, at 37ºC for
45 minutes, and then rinsed with 0.1M phosphate buffer (pH7.4) and distilled water. Finally
they were mounted in glycergel (19).

Results
Glucose levels of control rats and before STZ injection were 98±2 mg/dl (n:16). One week
after, glucose levels were significantly increased (P=<0.0001). It was 352 ±23 mg/dl (n:17) in
the first week and it remained at similar levels for 12 weeks (Table 1).
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Glucose (mg/dl)
Control

98±2 (n:16)

1 week

352±23 (n:17)

2 weeks

322±19 (n:7)

4 weeks

275±11 (n:7)

6 weeks

431±25 (n:7)

12 weeks

377±16 (n:7)

Table 1.

Glucose levels of control and
STZ injected animals during
experimental periods.

± :SE,

A control was prepared for NADPH-d reaction, treated with only nitroblue tetrozolium and
triton X-100 without NADPH-d. There was no histochemical reaction for NOS (Fig. 1). NADPHd reactions were localized exclusively at the sarcolemma and endothelial line of arterioles in control animals (Fig. 2a). In diabetic rats, a positive staining was observed at the sarcolemma of
muscle fibers, which did not occur in controls. In addition, several muscle fibers showed granular and diffuse sarcoplasmic NADPH-d reactions. These events are more clear in 6- and 12week diabetic animals (Fig. 2b). The arteriolar reaction was also smiliar in both 2- and 4-weeks
DM. There was no significant increase as compared to control slides (Fig. 3a, b). However,
when we looked at the eNOS histochemistry 6 weeks after STZ injection, endothelial NADPHd reaction was increased, and 2nd- and 3rd-order arterioles were more reactive, the branchial
points in particular having strong eNOS (Fig. 4). In 12-week DM, the histochemical reactions
of endothelial cells were greater than those of controls and other groups (Fig. 5a,b).

Figure 1.
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When cofactor was not applied
to the tissue, there was no
NADPH-d reaction. This shows
that NADPH detects NOS.
Muscle fiber (f) and arteriole
(a) X 400.
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Figure 2.

We saw less NADPH-d reaction (→) in muscle fibers (f) and arterioles (a) in control groups (A). (B) shows
increased NADPH-d reaction (→) in the sarcolemma, sarcoplasm and arteriole (a) of muscle in 12-week DM
X 800.

Figure 3.

There are no significant differences between control, 2-week and 4-week DM groups. In 2-weeks DM, the
NOS reaction (→) was almost the same as in the control group (A), and a similar reaction to those of 2weeks DM and controls was found in 4-week DM (B) X 400.
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Figure 4.

Figure 5.

Increased NOS histochemistry
(→) in 6-week diabetes was
observed when compared to
the control and 2- and 4-week
DM. The reaction was more
dense in the 2nd- and 3rdorder arterioles of experimental animals X 800.

NOS was firmly increased with STZ injection for 12 weeks. (A) and (B) show increased NADPH-d reaction
(→) of different-sized arterioles in 12-week DM X 400.

After blocking the NO production with L-NMA, there was no NADPH-d reaction in either the
arterioles or the sarcolemma of the muscle in the control animals. Some arterioles were also
contracted in these groups (Fig. 6a), whereas we observed eNOS reactions in some parts of the
arterioles and muscle fibers in 12-week diabetic rats that were superfused with L-NMA (Fig.
6b). After ACh and NP superfusion, the dilation of vessels was clear, but NP superfusion caused
more relaxation in both arterioles and muscles. NOS reactions were also significantly increased
after treatment with these drugs in the experimental groups (Figs. 7-8).
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Figure 6.

After L-NMA superfusion, since L-NMA inhibited NOS in the control group, there was no NADPH-d reaction
in both muscle fibers (f) and arterioles (a) (A). But L-NMA did not completely inhibit NOS in severe diabetes,
resulting in NADPH-d reaction (→) in some sarcolemma of muscle fibers (f) and endothelial cells of arterioles (a) in 12-week (B) DM X 800.

Figure 7.

After ACh superfusion, NOS reaction was lower in controls than in diabetics (A) and in 12-week DM (B),
NOS activity (→) was stronger X 400.
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Figure 8.

Dilated arterioles with NP in control group (A). Less reaction is seen. In (B) NOS activity is persistent in 12week DM because of the increased NO production X 400.

Discussion
We have shown that the enzyme NOS was increased in the skeletal muscle at 6 and 12
weeks of diabetes mellitus. Moreover, we have seen that the NADPH-d reaction in diabetic rats
was often localized also in the cytoplasm of muscle fibers in addition to the normal plasmalemmal localization. Cappani et al.(1998) reported that in aged rats the amount of nNOS in
the skeletal muscle increased both in the soluble and microsomal fractions and that an additional intracytoplasmic localization appeared (4). Neuronal NOS was localized to the sarcolemma of fast fibers; eNOS was associated with mitochondria. Isolated skeletal muscle produces NO
at low rates under resting conditions. NO appears to mediate cell-cell interactions in muscle,
including vasodilation and inhibition of leukocyte adhesion. Muscle metabolism also appears to
be NO-sensitive at several sites, including glucose uptake, glycolysis, mitochondrial oxygen consumption and creatine kinase activity (5). Young and Leighton (1998) have shown that NO
stimulates glucose transport and glucose oxidation in isolated, incubated rat skelatal muscle
preparations. Increased NO can stimulate glucose metabolism in skeletal muscle (20). On the
other hand, Way et al. (1999) studied anococcygeus muscle from diabetic rats, measuring NOS
activity and NADPH-d activity in the tissue, but found no significant differences between DM
and normal smooth muscles (21).
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We observed eNOS differences between groups and, especially 6 and 12 weeks after STZ
administration, NADPH-d reaction was increased. These results were clear in 2nd- and 3rdorder arterioles. We recently showed that vasoreactivity of arterioles were more pronounced
in larger arterioles than in smaller ones in DM (22). The vascular endothelium shows many
abnormalities in diabetes; among these, there seems to be a substantial defect in the normal
vasodilatory capacity of the endothelial cells. According to some investigators, the underlying
defect points towards a reduction in NO synthesis (8,14,15,16, 23, 24). However, some others have reported that NO synthesis increases in the endothelial cells during diabetes mellitus
(12,13, 25,). Our previous (22, 26) and present results showed that NO sythesis increased in
arterioles during the development of diabetes mellitus. Through the elevation of endothelial cell
calcium, D-glucose may lead to increased synthesis of NO (27). This mechanism may contribute
to the vasodilation and reduced peripheral resistance in the early stages of diabetes and the
associated increase in blood flow, and cause shear stress, which stimulates NO synthesis (28,
29). Hyperglylcemia also stimulates the polyol pathway, leading to an increase in sorbitol flux
and fructose synthesis through enhanced aldose reductase activity (30). Activation of the polyol pathway is associated with increased utilization of NADPH, which may lead to reduced availability of cellular NADPH, an essential cofactor of NO synthase (31). We observed increased
NADPH-d reaction in the endothelial cells of arterioles in 6- and 12-week diabetic animals, but
we saw no clear differences between controls and 2- 4-week diabetics. These results may be
related to utilization of NADPH in DM.
After blocking the NO production with L-NMA, saw no reaction to NADPH-d in control animals, whereas there were some reactions in the endothelial cells of arterioles 12 weeks after
the injection of STZ. This means NO production was increased in DM. ACh and NP superfusion
also showed similar results in 12-week DM. ACh, which is an endothelial dependent vasodilatory agent, causes the release of NO from endothelial cells, and NO stimulates cGMP, which
causes dilatation of the smooth muscle of the arterioles. The arterioles were dilated both in
controls and 12-week DM after adding ACh to the superfusate, but the NOS reaction was present in some parts of the arteriole, causing even maximal dilatation. NP is a NO donor, directly causing dilatation in the smooth muscle cells of the arterioles. When we superfused the muscle with NP, the NOS reaction was more pronounced in 12-week DM than incontrols.
It can be concluded that NO production increases in DM after 6 weeks.
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